Apeloa Pharmaceutical Co.,Ltd
Symbol: 000739.SZ
SHZ
14.01
CNYTrhová cena dnes
15.0522
Pomer P/E
0.3216
Pomer PEG
16.38B
MRK Cap
- 0.02%
Výnos DIV
Apeloa Pharmaceutical Co.,Ltd (000739-SZ) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 14812.83 | 3580.7 | 3552.9 | 2624.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | -65.1 | 0 | 0.1 | 14.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 10834.01 | 2420.6 | 2286.8 | 1804.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.inventory | 7885.31 | 2083.3 | 1801.8 | 1249.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 546.48 | 283.6 | 139.6 | 102.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 34078.64 | 8368.2 | 7781.1 | 5781.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 14152.56 | 3617.4 | 3405.9 | 2682.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill | 81.24 | 20.3 | 20.3 | 20.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 1284.29 | 319.8 | 378.8 | 407.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 1365.53 | 340.1 | 399.1 | 427.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 715.76 | 174 | 91.3 | 66.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 955.25 | 247.4 | 265.6 | 47.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 270.73 | 20.6 | 73.6 | 156.6 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 17459.84 | 4399.5 | 4235.5 | 3381.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-assets | 51538.48 | 12767.7 | 12016.6 | 9163.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.account-payables | 15550.44 | 2013.9 | 4310.6 | 2622.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 5990.9 | 3403.5 | 571.9 | 346.4 | ||||||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 383.56 | 77 | 117.6 | 190.7 | ||||||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 267.11 | 18.7 | 265.4 | 127.9 | ||||||||||||||||||||||||||||||
Deferred Revenue Non Current | 132.38 | 30.6 | 15.1 | 119.8 | ||||||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 418.6 | - | - | - | ||||||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 1435.26 | 460 | 685.9 | 18 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1079.97 | 198.9 | 470.8 | 324 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 32.69 | 4.5 | 15.8 | 22.9 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liab | 27012.14 | 6506.6 | 6497.4 | 4103.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.common-stock | 4714.09 | 1178.5 | 1178.5 | 1178.5 | ||||||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 17750.62 | 4520 | 3854.5 | 3240.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 1206.9 | 288.3 | 243 | 205.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 793.7 | 235.9 | 235.9 | 436.1 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 24465.32 | 6222.7 | 5511.9 | 5060 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 51538.48 | 12767.7 | 12016.6 | 9163.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 30.39 | 7.7 | 7.3 | 0 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-equity | 24495.71 | 6230.4 | 5519.2 | 5060 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 51538.48 | - | - | - | ||||||||||||||||||||||||||||||
Total Investments | 650.66 | 174 | 91.4 | 81.2 | ||||||||||||||||||||||||||||||
balance-sheet.row.total-debt | 6262.49 | 3426.7 | 837.3 | 474.3 | ||||||||||||||||||||||||||||||
balance-sheet.row.net-debt | -8550.35 | -154 | -2715.6 | -2135.7 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 1059.75 | 1055.3 | 989.2 | 955.6 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | -0.82 | 559 | 389.4 | 358.6 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 3.6 | -104 | -14 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1932.7 | 104 | 14 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -908.1 | -777.9 | -165.8 | -682.1 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -571.63 | -571.6 | -1108.1 | -851.4 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -373.35 | -373.3 | -603.1 | -190.1 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 0 | 130.2 | 1649.3 | 373.4 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | 36.87 | 36.9 | -104 | -14 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 937.72 | 2124.1 | 113.3 | -20.3 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1088.54 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -634.54 | -630.5 | -509.1 | -701.9 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 46.96 | 39.7 | 12.2 | 3.9 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -161.37 | -172.9 | -389 | -446.9 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 87.26 | 87.3 | 383.2 | 559.1 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | -8.73 | 0 | -88.6 | 70.5 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -670.42 | -676.4 | -591.3 | -515.4 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -814.12 | -96.5 | -712.7 | -698.2 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 200.2 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -200.2 | 0 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | -386.19 | -347.3 | -362.8 | -301.9 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | 913.9 | 141.9 | 879.4 | 795.8 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -366.84 | -301.9 | -196.1 | -204.3 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 39.7 | 27.5 | 44 | -17.3 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | -0.36 | 27.8 | 582.8 | -125.3 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 11369.38 | 3580.7 | 2381.9 | 1799.2 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 11369.75 | 3552.9 | 1799.2 | 1924.4 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 1088.54 | 1031.4 | 1326.1 | 611.7 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -634.54 | -630.5 | -509.1 | -701.9 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 454 | 400.9 | 817 | -90.2 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 11567.99 | 11418.1 | 10544.9 | 8942.6 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 8770.97 | 8686.6 | 8024.2 | 6569.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 2797.01 | 2731.5 | 2520.7 | 2373.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||||||
income-statement-row.row.research-development | 557.97 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 64.05 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 676.22 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -39.69 | -42 | 313.2 | 264.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 1686 | 1649.4 | 1456.1 | 1287.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 10456.97 | 10336 | 9480.3 | 7856.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-income | -22.64 | 113.6 | 75.8 | 75.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 34.1 | 47.2 | 59.2 | 35.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 676.22 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 66.36 | 119.3 | 0.4 | -5.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -39.69 | -42 | 313.2 | 264.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 66.36 | 119.3 | 0.4 | -5.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 34.1 | 47.2 | 59.2 | 35.7 | ||||||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 238.89 | 559 | 548 | 460.3 | ||||||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1379.21 | - | - | - | ||||||||||||||||||||||||||||||
income-statement-row.row.operating-income | 1140.32 | 1082.1 | 1011.6 | 1119.4 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 1206.68 | 1201.4 | 1012.1 | 1114.1 | ||||||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 149.86 | 149.3 | 22.9 | 158.5 | ||||||||||||||||||||||||||||||
income-statement-row.row.net-income | 1059.75 | 1055.3 | 989.2 | 955.6 |
Často kladené otázky
Čo je Apeloa Pharmaceutical Co.,Ltd (000739.SZ) celkové aktíva?
Apeloa Pharmaceutical Co.,Ltd (000739.SZ) celkové aktíva sú 12767664072.000.
Aký je ročný obrat podniku?
Ročné príjmy sú 6153438278.000.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.242.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 0.388.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.092.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.099.
Aká je Apeloa Pharmaceutical Co.,Ltd (000739.SZ) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 1055340740.000.
Aký je celkový dlh firmy?
Celkový dlh je 3426660858.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 1649394672.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 3716148377.000.